Literature DB >> 29117955

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Roderick A Corriveau1, Walter J Koroshetz2, Jordan T Gladman2, Sophia Jeon2, Debra Babcock2, David A Bennett2, S Thomas Carmichael2, Susan L-J Dickinson2, Dennis W Dickson2, Marian Emr2, Howard Fillit2, Steven M Greenberg2, Michael L Hutton2, David S Knopman2, Jennifer J Manly2, Karen S Marder2, Claudia S Moy2, Creighton H Phelps2, Paul A Scott2, William W Seeley2, Beth-Anne Sieber2, Nina B Silverberg2, Margaret L Sutherland2, Angela Taylor2, Christine L Torborg2, Salina P Waddy2, Amelie K Gubitz2, David M Holtzman2.   

Abstract

Goal 1 of the National Plan to Address Alzheimer's Disease is to prevent and effectively treat Alzheimer disease and Alzheimer disease-related dementias by 2025. To help inform the research agenda toward achieving this goal, the NIH hosts periodic summits that set and refine relevant research priorities for the subsequent 5 to 10 years. This proceedings article summarizes the 2016 Alzheimer's Disease-Related Dementias Summit, including discussion of scientific progress, challenges, and opportunities in major areas of dementia research, including mixed-etiology dementias, Lewy body dementia, frontotemporal degeneration, vascular contributions to cognitive impairment and dementia, dementia disparities, and dementia nomenclature.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 29117955      PMCID: PMC5719928          DOI: 10.1212/WNL.0000000000004717

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  53 in total

1.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Authors:  Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider
Journal:  Arch Neurol       Date:  2003-02

Review 2.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  The role of cerebral ischemia in Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

4.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

Review 5.  Recommendations of the Alzheimer's disease-related dementias conference.

Authors:  Thomas J Montine; Walter J Koroshetz; Debra Babcock; Dennis W Dickson; Wendy R Galpern; M Maria Glymour; Steven M Greenberg; Michael L Hutton; David S Knopman; Andrey N Kuzmichev; Jennifer J Manly; Karen S Marder; Bruce L Miller; Creighton H Phelps; William W Seeley; Beth-Anne Sieber; Nina B Silverberg; Margaret Sutherland; Christine L Torborg; Salina P Waddy; Berislav V Zlokovic; Roderick A Corriveau
Journal:  Neurology       Date:  2014-07-30       Impact factor: 9.910

6.  Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.

Authors:  Manabu Ikeda; Etsuro Mori; Kenji Kosaka; Eizo Iseki; Mamoru Hashimoto; Noriyuki Matsukawa; Kazutaka Matsuo; Masaki Nakagawa
Journal:  Dement Geriatr Cogn Disord       Date:  2013-08-15       Impact factor: 2.959

7.  Prevalence of dementia disorders in the oldest-old: an autopsy study.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Acta Neuropathol       Date:  2010-03-04       Impact factor: 17.088

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

9.  Rates of formal diagnosis of dementia in primary care: The effect of screening.

Authors:  Tilly Eichler; Jochen René Thyrian; Johannes Hertel; Bernhard Michalowsky; Diana Wucherer; Adina Dreier; Ingo Kilimann; Stefan Teipel; Wolfgang Hoffmann
Journal:  Alzheimers Dement (Amst)       Date:  2015-03-29

10.  Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Authors:  Jose Bras; Rita Guerreiro; Lee Darwent; Laura Parkkinen; Olaf Ansorge; Valentina Escott-Price; Dena G Hernandez; Michael A Nalls; Lorraine N Clark; Lawrence S Honig; Karen Marder; Wiesje M Van Der Flier; Afina Lemstra; Philip Scheltens; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Sara Ortega-Cubero; Pau Pastor; Tanis J Ferman; Neill R Graff-Radford; Owen A Ross; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Walter Maetzler; Daniela Berg; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Yaroslau Compta; Tamas Revesz; Andrew Lees; Nigel Cairns; Glenda M Halliday; David Mann; Stuart Pickering-Brown; Dennis W Dickson; Andrew Singleton; John Hardy
Journal:  Hum Mol Genet       Date:  2014-06-27       Impact factor: 6.150

View more
  53 in total

Review 1.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 2.  Research Progress on Alzheimer's Disease and Resveratrol.

Authors:  Yan Yan; Huihuang Yang; Yuxun Xie; Yuanlin Ding; Danli Kong; Haibing Yu
Journal:  Neurochem Res       Date:  2020-03-11       Impact factor: 3.996

3.  Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018.

Authors:  Andrea Denny; Marissa Streitz; Kristin Stock; Joyce E Balls-Berry; Lisa L Barnes; Goldie S Byrd; Raina Croff; Sujuan Gao; Crystal M Glover; Hugh C Hendrie; William T Hu; Jennifer J Manly; Krista L Moulder; Susan Stark; Stephen B Thomas; Rachel Whitmer; Roger Wong; John C Morris; Jennifer H Lingler
Journal:  Alzheimers Dement       Date:  2020-08-17       Impact factor: 21.566

Review 4.  A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review.

Authors:  Dana R Jorgensen; C Elizabeth Shaaban; Clayton A Wiley; Peter J Gianaros; Joseph Mettenburg; Caterina Rosano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-02       Impact factor: 4.733

5.  Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences.

Authors:  David C Goff; Denis B Buxton; Gail D Pearson; Gina S Wei; Teri E Gosselin; Ebyan A Addou; Catherine M Stoney; Patrice Desvigne-Nickens; Pothur R Srinivas; Zorina S Galis; Charlotte Pratt; Kit Brian K Kit; Christine Maric-Bilkan; Holly L Nicastro; Renee P Wong; Vandana Sachdev; Jue Chen; Lawrence Fine
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

6.  Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.

Authors:  Chin Hong Tan; Luke W Bonham; Chun Chieh Fan; Elizabeth C Mormino; Leo P Sugrue; Iris J Broce; Christopher P Hess; Jennifer S Yokoyama; Gil D Rabinovici; Bruce L Miller; Kristine Yaffe; Gerard D Schellenberg; Karolina Kauppi; Dominic Holland; Linda K McEvoy; Walter A Kukull; Duygu Tosun; Michael W Weiner; Reisa A Sperling; David A Bennett; Bradley T Hyman; Ole A Andreassen; Anders M Dale; Rahul S Desikan
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

7.  Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment.

Authors:  Andrea M Kurasz; Glenn E Smith; Maria G McFarland; Melissa J Armstrong
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.

Authors:  Adam L Boxer; Michael Gold; Howard Feldman; Bradley F Boeve; Susan L-J Dickinson; Howard Fillit; Carole Ho; Robert Paul; Rodney Pearlman; Margaret Sutherland; Ajay Verma; Stephen P Arneric; Brian M Alexander; Bradford C Dickerson; Earl Ray Dorsey; Murray Grossman; Edward D Huey; Michael C Irizarry; William J Marks; Mario Masellis; Frances McFarland; Debra Niehoff; Chiadi U Onyike; Sabrina Paganoni; Michael A Panzara; Kenneth Rockwood; Jonathan D Rohrer; Howard Rosen; Robert N Schuck; Holly D Soares; Nadine Tatton
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

Review 9.  Cellular senescence and Alzheimer disease: the egg and the chicken scenario.

Authors:  Sara Saez-Atienzar; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2020-06-29       Impact factor: 34.870

Review 10.  Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.

Authors:  Vivian Hook; Michael Yoon; Charles Mosier; Gen Ito; Sonia Podvin; Brian P Head; Robert Rissman; Anthony J O'Donoghue; Gregory Hook
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-17       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.